ATYR Q4 2024 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$12M

Operating Income

-$16M

Net Income

-$15M

EPS (Diluted)

$-0.18

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$770,000

Balance Sheet

Total Assets

$97M

Total Liabilities

$27M

Stockholders' Equity

$70M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$12M	-$407,000	-2904.4%
Operating Income	-$16M	-$16M	+0.9%
Net Income	-$15M	-$15M	-1.4%